FNY Managed Accounts’s DMK Pharmaceuticals DMK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q1
$2K Hold
11
– – ﹤0.01% 450
2017
Q4
$3K Buy
+11
New +$3.62K ﹤0.01% 475

Other funds holding DMK

FNY Managed Accounts's DMK Position: Q1 2018 in Review

FNY Managed Accounts held its DMK Pharmaceuticals (DMK) position steady in Q1 2018 at 11 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #450.

FNY Managed Accounts first reported a position in DMK in Q4 2017 and has held it in 2 quarters since. The position peaked at $3K in Q4 2017. 52 funds tracked by Wall St. Rank hold DMK as of Q1 2018.

  • FNY Managed Accounts held 11 shares of DMK Pharmaceuticals worth $2K as of Q1 2018.
  • FNY Managed Accounts left its DMK Pharmaceuticals share count unchanged in Q1 2018.
  • DMK Pharmaceuticals made up ﹤0.01% of FNY Managed Accounts's portfolio in Q1 2018, its #450 holding.
  • FNY Managed Accounts first reported a position in DMK Pharmaceuticals in Q4 2017 and has held it in 2 quarters since.
  • FNY Managed Accounts's DMK Pharmaceuticals position peaked at $3K in Q4 2017.
  • 52 funds tracked by Wall St. Rank held DMK Pharmaceuticals as of Q1 2018.

Based on FNY Managed Accounts's 13F filing for Q1 2018, filed 18 Apr 2018.